Posts tagged ‘Conference Coverage’
Now that summer is officially over, the fall pharma/biotech conference season has started. You can find out details of the conferences Icarus Consultants will be attending by checking out our conference schedule.
If you are interested in our meeting coverage services or a conference report, please contact us.
This week, we followed two conferences remotely through Twitter. On Biotech Strategy Blog, Pieter Droppert aggregated the tweets from the BioPharm America 2011 partnering conference in Boston.
The joy of twitter is that you can follow the key messages of conference presenters remotely. It’s no substitute for being at the meeting and the networking opportunities in person, but it does allow you to capture a flavor of what everyone is thinking. 140 characters allows for a good sound bite!
Meanwhile on Pharma Strategy Blog, Sally Church has been following the ASCO Breast Cancer Symposium 2011 in San Francisco. Icarus Consultants will be at the San Antonio Breast Cancer Symposium (SABCS) later this year.
On Pharma Strategy Blog, Sally also wrote about the European Multidisciplinary Cancer Conference in Stockholm, more commonly known as ECCO or ESMO. The conference abstracts will be available on Monday, so we look forward to Sally’s video preview and thoughts on what’s hot at the meeting.
Following on from an exciting American Society of Clinical Oncology (ASCO) meeting, this Friday sees the start of the 16th Congress of the European Hematology Association (EHA).
The annual EHA meeting runs from Friday June 10 through Sunday June 12, 2011 at the ExCeL conference center in London’s Docklands.
Sally Church will be traveling from Chicago to London, and aggregating tweets from the meeting on Pharma Strategy Blog (hashtag #EHA11). Should you be unable to attend, you can listen in on the conversation remotely.
Sally will also be publishing video blogs about the exciting scientific data presented at ASCO and EHA when she returns to New Jersey next week. Stay tuned!
News from ARVO 2011 annual meeting including Lucentis v Avastin in age-related macular degeneration
May 6th, 2011
Daedalus
Pieter Droppert recently attended the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Fort Lauderdale.
Earlier in his career, Pieter worked in ophthalmology with Alcon Labs on European clinical trials for novel intra-ocular lenses. He helped bring AcrySof® to market.
Hot news at this year’s ARVO was a discussion on the data published in the New England Journal of Medicine comparing FDA approved Lucentis® to off-label Avastin® in age-related macular degeneration (AMD).
If you are interested in the ophthalmology market or news from ARVO, Pieter has recently written a number of posts on Biotech Strategy Blog that are worth checking out:
At the recent annual meeting of the American Association for Cancer Research (AACR) in Orlando, Sally Church on Pharma Strategy Blog, chose a poster by patient advocate, Leslie Hammersmith as “My AACR Poster of the Day.” A hard won accolade in a field of more than 5000 posters!
One of the attractions of this poster, (and you can read more about why Sally chose it on Pharma Strategy Blog) was its use of social media, and particular quick response (QR) codes.
QR codes are a matrix bar code that is now easily readable by smart phones, you can readily find apps for the iPhone. By scanning the QR code using the camera in the phone you are automatically directed to further information – whether it be a copy of the poster, a scientific paper or a website.
As Sally said in her blog post about Leslie’s poster, “The clever use of QR codes made me want it on all the science posters too.” A few other science researchers did have QR codes on their posters, and we see this as a social media trend that will expand.
We will be adding a QR code to our next print run of business cards, will you?
Greetings from sunny Orlando and the AACR 102nd annual meeting 2011, one of the highlights of the year for those interested in the science of cancer and emerging new products.
For those of you who couldn’t afford a last minute Continental flight from Newark (does it really cost $600 to fly to Orlando?), Pharma Strategy Blog has a Covert it Live widget that aggregates all #AACR tweets.
While this is no substitute for actually attending, it does provide a window into what’s happening. Sally Church also plans to provide a daily video update, so watch Pharma Strategy Blog for the hot news from the American Association for Cancer Research annual meeting.
We are excited to hear that Sally Church has produced another video to follow on from her recent video debut on Pharma Strategy Blog.
Produced by the aptly named, “PSB Films”, it is a trailer for her eagerly awaited post on “What’s hot at AACR 2011?”
Readers of Sally’s blog will know that prior to major scientific meetings such as AACR, ASCO and ASH, Sally often provides a mixture of commentary and insight on what she predicts will be hot topics.
Happy April 1st!
As many of you know, Sally Church attended the recent European Association of Urology Congress in Vienna.
In the first video blog post that she’s ever done on Pharma Strategy Blog, she shares her impressions of the meeting and the changing landscape in advanced prostate cancer. One of the key new product approvals expected this year is for abiraterone.
We love the “BBC News” style graphics of her video blog, and look forward to hearing from Sally throughout the course of the year as she attends other conferences.
You can now watch Sally on her own YouTube channel. Will we see “Sally Church reporting live for Pharma Strategy Blog”?
Sally Church on Pharma Strategy Blog will be providing live coverage of the annual European Association of Urology (EAU) Congress that starts in Vienna this weekend.
If you can’t join Sally at the meeting for a slice of schwarzwälder kirschtorte, then you can experience the meeting virtually as Sally aggregates all the live tweets, and contributes her own.
There are a lot of new products in the prostate cancer market. With new treatment options such as Dendreon’s sipuleucel-T, sanofi-aventis’ cabizatexel and JNJ’s abiraterone expected in the not too distant future, the meeting is bound to be interesting. We can also expect the latest news about new product development in bladder and renal cancer.
The Cover it Live widget on Sally’s blog will be aggregating all the tweets that use the conference hashtag #EAU11, so if you are unable to be in Vienna, you can follow what’s happening by clicking here.
Photo Werner Kunz via flickr
Icarus Consultants will be at the forthcoming European Urology Association annual meeting in Vienna, Austria from March 18-22, 2011.
If you are going to be in Vienna and would be interested in meeting up for Kaffee Und Kuchen, please contact us.
Incidentally, our favorite is a slice of Schwarzwälder Kirschtorte (Black Forest gateau).
Sally Church on Pharma Strategy Blog will be providing live coverage of the AACR PI3-Kinase conference that starts today in San Francisco.
Sally AKA @MaverickNY will be live tweeting from the event that starts at 7pm (california time) today, Thursday, February 24 and runs through Sunday morning, February 27. The Cover it Live widget on her blog will be aggregating all the tweets that use the conference hashtag #PI3K, so if you are unable to be in San Francisco, you can follow what’s happening by clicking here.
This AACR special conference has an impressive line-up of leading key opinion leaders and experts in the field. The keynote session this evening is on “Targeting PI3K/mTOR in breast cancer” by Jose Baselga, from Mass General. The session chair is Lewis Cantley.
Some of the new products in development that will be discussed at the meeting include: GSK2126458, INK1117, AZD8055, MK-2206 and SAR245408 (XL147). If you are interested in purchasing an Icarus Consultants in-depth meeting report, do contact us.